XML 32 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Stock-Based Compensation (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2017
USD ($)
$ / shares
shares
Jun. 30, 2016
USD ($)
Jun. 30, 2017
USD ($)
Plan
$ / shares
shares
Jun. 30, 2016
USD ($)
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Share-based Compensation [Abstract]          
Number of stock based compensation plans | Plan     1    
Additional Disclosures [Abstract]          
Proceeds from stock option exercises     $ 258,250 $ 177,250  
Closing price of common stock (in dollars per share) | $ / shares $ 49.51   $ 49.51    
General and Administrative [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]          
Stock-based compensation expense $ 33,000 $ 34,000 $ 67,000 $ 67,000  
Stock Options [Member]          
Stock Options Activity [Roll Forward]          
Outstanding, beginning of period (in shares) | shares     297,000    
Grants (in shares) | shares     0 0  
Exercised (in shares) | shares     (20,000)    
Forfeitures or expirations (in shares) | shares     0    
Outstanding, end of period (in shares) | shares 277,000   277,000   297,000
Exercisable, end of period (in shares) | shares 238,250   238,250    
Weighted Average Exercise Price [Roll Forward]          
Outstanding, beginning of period (in dollars per share) | $ / shares     $ 20.14    
Grants (in dollars per share) | $ / shares     0    
Exercised (in dollars per share) | $ / shares     12.91    
Forfeitures or expirations (in dollars per share) | $ / shares     0    
Outstanding, end of period (in dollars per share) | $ / shares $ 20.66   20.66   $ 20.14
Exercisable, end of period (in dollars per share) | $ / shares $ 18.92   $ 18.92    
Weighted Average Remaining Contractual Term [Roll Forward]          
Outstanding     2 years 8 months 26 days   3 years 1 month 6 days
Grants     0 years    
Exercised     0 years    
Forfeitures or expirations     0 years    
Exercisable     2 years 4 months 20 days    
Aggregate Intrinsic Value [Roll Forward]          
Outstanding, beginning of period     $ 10,561,380    
Grants     0    
Exercised     0    
Forfeitures or expirations     0    
Outstanding, end of period $ 7,991,000   7,991,000   $ 10,561,380
Exercisable, end of period 7,288,450   7,288,450    
Additional Disclosures [Abstract]          
Proceeds from stock option exercises     258,250 $ 177,250  
Unrecognized compensation cost $ 201,000   $ 201,000    
Recognized compensation period     1 year 9 months 18 days